Viewing Study NCT03620903


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-01-04 @ 7:57 AM
Study NCT ID: NCT03620903
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2018-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia
Sponsor: Christian Buske
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ECWM-2
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View
None INDUSTRY View
None INDUSTRY View
None OTHER View